NLRP3 and breast cancer: Breast cancer cells (Figure 7B,N) and cardiomyocytes (Figure 7G) under high glucose and exposed to ipilimumab showed a considerably higher amount of NLRP3 (green signals) than the control (Figure 7A,F,M).